ID22770A - Turunan (1,3-bis(sikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenil tersubstitusi, pembuatan dan penggunaannya dalam perawatan pada kondisi peradangan dan penyakit kekebalan - Google Patents

Turunan (1,3-bis(sikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenil tersubstitusi, pembuatan dan penggunaannya dalam perawatan pada kondisi peradangan dan penyakit kekebalan

Info

Publication number
ID22770A
ID22770A IDW990879A ID990879A ID22770A ID 22770 A ID22770 A ID 22770A ID W990879 A IDW990879 A ID W990879A ID 990879 A ID990879 A ID 990879A ID 22770 A ID22770 A ID 22770A
Authority
ID
Indonesia
Prior art keywords
disease
durunan
cyclohexcylmetyl
tobal
dioxos
Prior art date
Application number
IDW990879A
Other languages
English (en)
Inventor
Susan Mary Daluge
Douglas Alan Livingstone
Gerald Wolberg
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID22770A publication Critical patent/ID22770A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW990879A 1997-02-14 1998-02-12 Turunan (1,3-bis(sikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenil tersubstitusi, pembuatan dan penggunaannya dalam perawatan pada kondisi peradangan dan penyakit kekebalan ID22770A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9703044.9A GB9703044D0 (en) 1997-02-14 1997-02-14 Phenyl xanthine esters and amides

Publications (1)

Publication Number Publication Date
ID22770A true ID22770A (id) 1999-12-09

Family

ID=10807635

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990879A ID22770A (id) 1997-02-14 1998-02-12 Turunan (1,3-bis(sikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenil tersubstitusi, pembuatan dan penggunaannya dalam perawatan pada kondisi peradangan dan penyakit kekebalan

Country Status (37)

Country Link
US (3) US6355646B1 (id)
EP (1) EP0970081B1 (id)
JP (1) JP2001511792A (id)
KR (1) KR100522639B1 (id)
CN (1) CN1140527C (id)
AP (1) AP1000A (id)
AR (1) AR011441A1 (id)
AT (1) ATE304542T1 (id)
AU (1) AU754456B2 (id)
BG (1) BG103722A (id)
BR (1) BR9807682B1 (id)
CA (1) CA2280730C (id)
CO (1) CO4940444A1 (id)
CZ (1) CZ298764B6 (id)
DE (1) DE69831559T2 (id)
DK (1) DK0970081T3 (id)
EA (1) EA199900648A1 (id)
EE (1) EE9900348A (id)
ES (1) ES2249822T3 (id)
GB (1) GB9703044D0 (id)
HR (1) HRP980077A2 (id)
HU (1) HU225962B1 (id)
ID (1) ID22770A (id)
IL (1) IL131179A (id)
IS (1) IS5144A (id)
MY (1) MY118545A (id)
NO (1) NO325685B1 (id)
NZ (1) NZ336923A (id)
PE (1) PE58899A1 (id)
PL (1) PL188018B1 (id)
SK (1) SK110399A3 (id)
TR (1) TR199901942T2 (id)
TW (1) TW520371B (id)
UA (1) UA57767C2 (id)
WO (1) WO1998035966A1 (id)
YU (1) YU38399A (id)
ZA (1) ZA981175B (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
US6545002B1 (en) * 1999-06-01 2003-04-08 University Of Virginia Patent Foundation Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
WO2002067942A2 (en) * 2001-02-28 2002-09-06 Smithkline Beecham Corporation Methods of treating irritable bowel syndrome and functional dyspepsia
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US20040072848A1 (en) * 2002-02-26 2004-04-15 Huber Brian E Methods of treating irritable bowel syndrome and functional dyspepsia
WO2005058367A2 (en) * 2003-12-16 2005-06-30 Nektar Therapeutics Al, Corporation Pegylated small molecules
AU2012227249B2 (en) * 2003-12-16 2014-10-02 Nektar Therapeutics Chemically modified small molecules
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
WO2005102976A1 (en) * 2004-04-21 2005-11-03 Smithkline Beecham Corporation Process for preparing nonaethylene glycol monomethyl ether
US20060058322A1 (en) * 2004-09-01 2006-03-16 Dewan Zeng Method of wound healing using A2B adenosine receptor antagonists
US20070059740A1 (en) * 2005-08-26 2007-03-15 Linden Joel M Method of targeting a2b adenosine receptor antagonist therapy
US8193200B2 (en) * 2007-01-04 2012-06-05 University Of Virginia Patent Foundation Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
US4968672A (en) 1987-01-02 1990-11-06 The United States Of America As Represented By The Department Of Health And Human Services Adenosine receptor prodrugs
US5015647A (en) 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
GB8826595D0 (en) 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
IL100088A (en) 1990-11-21 1995-07-31 Smithkline Beecham Corp FNT inhibitor preparations containing histogenic transducts converted at positions 1, 3, and 8
GB9210839D0 (en) 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
TW252044B (id) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
GB9415529D0 (en) * 1994-08-01 1994-09-21 Wellcome Found Phenyl xanthine derivatives
DE19535504A1 (de) 1995-09-25 1997-03-27 Bayer Ag Substituierte Xanthine
ES2185837T3 (es) * 1996-06-07 2003-05-01 Hoechst Ag Utilizacion de derivados de teofilina para el tratamiento y la profilaxis de las enfermedades de choque, nuevos compuestos de xantina y procedimientos para su produccion.
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
US6117878A (en) 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
WO1999043673A1 (en) 1998-02-26 1999-09-02 Zenyaku Kogyo Kabushiki Kaisha 1-azaindolizine derivatives
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
AP2002002582A0 (en) 1999-12-23 2002-09-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
US6751206B1 (en) * 2000-06-29 2004-06-15 Qualcomm Incorporated Method and apparatus for beam switching in a wireless communication system

Also Published As

Publication number Publication date
AR011441A1 (es) 2000-08-16
EP0970081A1 (en) 2000-01-12
KR100522639B1 (ko) 2005-10-19
AP9901622A0 (en) 1999-09-30
YU38399A (sh) 2002-06-19
EE9900348A (et) 2000-02-15
ZA981175B (en) 1999-08-12
SK110399A3 (en) 2000-06-12
US7002012B2 (en) 2006-02-21
UA57767C2 (uk) 2003-07-15
BG103722A (en) 2000-06-30
DE69831559D1 (de) 2005-10-20
AU754456B2 (en) 2002-11-14
CN1140527C (zh) 2004-03-03
AU6622198A (en) 1998-09-08
HRP980077A2 (en) 1998-12-31
NZ336923A (en) 2001-02-23
AP1000A (en) 2001-08-11
IL131179A0 (en) 2001-01-28
ES2249822T3 (es) 2006-04-01
NO993915D0 (no) 1999-08-13
DE69831559T2 (de) 2006-06-14
BR9807682B1 (pt) 2009-01-13
HUP0000894A3 (en) 2002-04-29
NO325685B1 (no) 2008-07-07
US6437124B1 (en) 2002-08-20
CA2280730C (en) 2006-10-10
JP2001511792A (ja) 2001-08-14
TR199901942T2 (xx) 1999-12-21
PL335135A1 (en) 2000-04-10
CZ298764B6 (cs) 2008-01-23
ATE304542T1 (de) 2005-09-15
HUP0000894A2 (hu) 2001-05-28
MY118545A (en) 2004-12-31
CO4940444A1 (es) 2000-07-24
DK0970081T3 (da) 2006-02-06
EP0970081B1 (en) 2005-09-14
IL131179A (en) 2004-05-12
CA2280730A1 (en) 1998-08-20
US20030181471A1 (en) 2003-09-25
CZ288799A3 (cs) 2000-04-12
TW520371B (en) 2003-02-11
US6355646B1 (en) 2002-03-12
HK1022907A1 (en) 2000-08-25
WO1998035966A1 (en) 1998-08-20
NO993915L (no) 1999-10-13
GB9703044D0 (en) 1997-04-02
PL188018B1 (pl) 2004-11-30
CN1252071A (zh) 2000-05-03
BR9807682A (pt) 2000-02-15
IS5144A (is) 1999-07-30
KR20000071010A (ko) 2000-11-25
PE58899A1 (es) 1999-06-17
HU225962B1 (en) 2008-01-28
EA199900648A1 (ru) 2000-04-24

Similar Documents

Publication Publication Date Title
ID22770A (id) Turunan (1,3-bis(sikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenil tersubstitusi, pembuatan dan penggunaannya dalam perawatan pada kondisi peradangan dan penyakit kekebalan
ATE214590T1 (de) Körperpflegezusammensetzungen
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
DE69712278D1 (de) Verdicktes Körperpflegemittel
ID24652A (id) Komposisi untuk penggunaan pada perawatan pribadi
ITMI951278A0 (it) Formulazioni di analoghi dell'insulina
ID25504A (id) Pencegahan dan pengobatan penyakit amiloidogenik
ID22926A (id) Komposisi untuk perawatan rambut
DE69941113D1 (de) Zytokinen und mitogenen um "graft-versus-host disease" zu verhindern
ITMI951277A0 (it) Formulazioni di analoghi monomerici dell'insulina
DE19882513T1 (de) Dental-Restorative Massen
IL122084A0 (en) Improved personal care formulations
ATE199314T1 (de) Kosmetische tensid zusammensetzung sowie ihre verwendung
NO981388L (no) Bedring av Dupuytrens sykdom
ATE303791T1 (de) Körperpflegemittel
EP1210933A4 (en) ACTIVE SUBSTANCES FOR NORMALIZING THE SKIN CONDITION
ID25489A (id) Komposisi perawatan rambut
ID19975A (id) Komposisi perawatan rambut
DE69510575D1 (de) Verwendung von silikontrennschichtmittel
EP1019091A4 (en) 50 SECRETED PROTEINS OF HUMAN ORIGIN
DE69713171D1 (de) Mundpflegezubereitung
ATE213149T1 (de) Reinigende kosmetische zusammensetzung und verwendung
ID27215A (id) Komposisi perawatan rambut
ID22656A (id) Komposisi untuk digunakan pada rambut atau kulit
DE69500099D1 (de) N-(Hydroxyalkyl)-substituierte Alkylcarbamate und ihre Verwendung in der Kosmetik, insbesondere in Haarpflegemitteln